BACKGROUND: Sarcomas are rare cancers with great variability in clinical and histopathological presentation. The main objective of clinical practice guidelines (CPGs) is to standardize diagnosis and treatment. METHODS: From March 2005 to February 2007, all patients diagnosed with localized sarcoma in the Rhône-Alpes region were included in a cohort-based study, to evaluate the compliance of sarcoma management with French guidelines in routine practice and to identify predictive factors for compliance with CGPs. RESULTS: 634 (71 %) patients with localized sarcoma satisfying the inclusion criteria were included out of 891 newly diagnosed sarcomas. Taking into account initial diagnosis until follow-up, overall conformity to CPGs was only 40 % [95 % confidence interval (CI) = 36-44], ranging from 54 % for gastrointestinal stromal tumor to 36 % for soft tissue sarcoma and 42 % for bone sarcoma. In multivariate analysis, primary tumor type [relative risk (RR) = 4.42, 95 % CI = 2.79-6.99, p < 0.001], dedicated multidisciplinary staff before surgery (RR = 4.19, 95 % CI = 2.39-7.35, p < 0.001) and management in specialized hospitals (RR = 3.71, 95 % CI = 2.43-5.66, p < 0.001) were identified as unique independent risk factors for conformity to CPGs for overall treatment sequence. CONCLUSIONS: With only 40 % of total conformity to CPGs, the conclusions support the improvement of initial sarcoma management and its performance in specialized centres or within specialized dedicated networks.
BACKGROUND:Sarcomas are rare cancers with great variability in clinical and histopathological presentation. The main objective of clinical practice guidelines (CPGs) is to standardize diagnosis and treatment. METHODS: From March 2005 to February 2007, all patients diagnosed with localized sarcoma in the Rhône-Alpes region were included in a cohort-based study, to evaluate the compliance of sarcoma management with French guidelines in routine practice and to identify predictive factors for compliance with CGPs. RESULTS: 634 (71 %) patients with localized sarcoma satisfying the inclusion criteria were included out of 891 newly diagnosed sarcomas. Taking into account initial diagnosis until follow-up, overall conformity to CPGs was only 40 % [95 % confidence interval (CI) = 36-44], ranging from 54 % for gastrointestinal stromal tumor to 36 % for soft tissue sarcoma and 42 % for bone sarcoma. In multivariate analysis, primary tumor type [relative risk (RR) = 4.42, 95 % CI = 2.79-6.99, p < 0.001], dedicated multidisciplinary staff before surgery (RR = 4.19, 95 % CI = 2.39-7.35, p < 0.001) and management in specialized hospitals (RR = 3.71, 95 % CI = 2.43-5.66, p < 0.001) were identified as unique independent risk factors for conformity to CPGs for overall treatment sequence. CONCLUSIONS: With only 40 % of total conformity to CPGs, the conclusions support the improvement of initial sarcoma management and its performance in specialized centres or within specialized dedicated networks.
Authors: Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun Journal: CA Cancer J Clin Date: 2004 Jan-Feb Impact factor: 508.702
Authors: Antoine Lurkin; Francoise Ducimetière; Dominique Ranchère Vince; Anne-Valérie Decouvelaere; Dominic Cellier; François N Gilly; Dimitri Salameire; Pierre Biron; Guy de Laroche; Jean Yves Blay; Isabelle Ray-Coquard Journal: BMC Cancer Date: 2010-04-19 Impact factor: 4.430
Authors: I Ray-Coquard; M C Montesco; J M Coindre; A P Dei Tos; A Lurkin; D Ranchère-Vince; A Vecchiato; A V Decouvelaere; S Mathoulin-Pélissier; S Albert; P Cousin; D Cellier; L Toffolatti; C R Rossi; J Y Blay Journal: Ann Oncol Date: 2012-02-13 Impact factor: 32.976
Authors: Carol J Swallow; Dirk C Strauss; Sylvie Bonvalot; Piotr Rutkowski; Anant Desai; Rebecca A Gladdy; Ricardo Gonzalez; David E Gyorki; Mark Fairweather; Winan J van Houdt; Eberhard Stoeckle; Jae Berm Park; Markus Albertsmeier; Carolyn Nessim; Kenneth Cardona; Marco Fiore; Andrew Hayes; Dimitri Tzanis; Jacek Skoczylas; Samuel J Ford; Deanna Ng; John E Mullinax; Hayden Snow; Rick L Haas; Dario Callegaro; Myles J Smith; Toufik Bouhadiba; Silvia Stacchiotti; Robin L Jones; Thomas DeLaney; Christina L Roland; Chandrajit P Raut; Alessandro Gronchi Journal: Ann Surg Oncol Date: 2021-04-14 Impact factor: 4.339
Authors: Harald J Hoekstra; Rick L M Haas; Cornelis Verhoef; Albert J H Suurmeijer; Carla S P van Rijswijk; Ben G H Bongers; Winette T van der Graaf; Vincent K Y Ho Journal: Ann Surg Oncol Date: 2017-07-26 Impact factor: 5.344
Authors: J-Y Blay; C Honoré; E Stoeckle; P Meeus; M Jafari; F Gouin; P Anract; G Ferron; A Rochwerger; M Ropars; S Carrere; F Marchal; F Sirveaux; A Di Marco; L R Le Nail; J Guiramand; G Vaz; J-C Machiavello; O Marco; S Causeret; P Gimbergues; F Fiorenza; L Chaigneau; F Guillemin; J-M Guilloit; F Dujardin; J-P Spano; J-C Ruzic; A Michot; P Soibinet; E Bompas; C Chevreau; F Duffaud; M Rios; C Perrin; N Firmin; F Bertucci; C Le Pechoux; F Le Loarer; O Collard; M Karanian-Philippe; M Brahmi; A Dufresne; A Dupré; F Ducimetière; A Giraud; D Pérol; M Toulmonde; I Ray-Coquard; A Italiano; A Le Cesne; N Penel; S Bonvalot Journal: Ann Oncol Date: 2019-07-01 Impact factor: 32.976
Authors: J-Y Blay; P Casali; C Bouvier; C Dehais; I Galloway; J Gietema; J Halámková; N Hindi; A Idbaih; E Kinloch; H-J Klümpen; T Kolarova; K Kopeckova; J Lovey; M Magalhaes; K Oselin; S Piperno-Neumann; A Ravnsbaek; M Rogasik; A Safwat; S Scheipl; M Seckl; J Taylor; M Temnyk; A Trama; M Urbonas; M Wartenberg; A Weinman Journal: ESMO Open Date: 2021-06-14